Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Factor Bioscience Adds Kyle Garland, Ph.D. As Director of Translational Science

RECENTLY ACQUIREDApr 09, 2024•about 2 years ago

Position

Vice President of Research and Development

Company

Factor Bioscience

Kyle Garland

CambridgeBiotechnologyHealth Care

Description

Factor Bioscience Inc. announced the addition of three members to its translational science team, led by Kyle Garland, Ph.D., who joins as Director of Translational Science.

Company Information

Company

Factor Bioscience

Location

Cambridge, Massachusetts, United States

About

Factor Bioscience was founded to pioneer new methods for controlling gene expression and cell fate. The company innovates across mRNA, gene editing, cell reprogramming, and nucleic acid delivery. With more than 150 granted patents, Factor Bioscience has helped unlock the potential of mRNA to treat disease and improve lives. Factor supports a model of unlimited discovery, believing that breakthroughs happen when scientists are given the freedom and resources to pursue bold ideas. At Factor Bioscience, science is the business. Partner with Factor Bioscience to build the next generation of cell therapies, gene therapies, and RNA therapeutics.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Factor Bioscience's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months